Julie A. Losman

1.7k citations
11 papers · 1.4k indexed · 1 hit paper · h-index 11
Topics
Cytokine Signaling Pathways and Interactions (7 papers)Pharmacological Effects of Natural Compounds (3 papers)Cancer Mechanisms and Therapy (2 papers)
Partner nations
United StatesItalyCanada

In The Last Decade

Julie A. Losman

11 papers receiving 1.3k citations

Hit Papers

Transformation by the (R)-enantiomer of 2-hydroxyglutarat...20122026201620212012100200300400500

Peers

Julie A. Losman
Comparison fields: 5 of 84
  • Molecular Biology 634
  • Oncology 516
  • Cancer Research 451
  • Immunology 441
  • Genetics 232
Replace Franz Kohlhuber with:
Franz Kohlhuber Germany
David J. Panka United States
Hisaki Nagai Japan
Joe Stephenson United States
Tsung H. Lin United States
Kathryn O’Reilly United States
Mark A. Gregory United States
Mei Dong China
Suzanne Schubbert United States
Yijiang Shi United States
Julie A. Losman relative to Franz Kohlhuber Germany Franz Kohlhuber's profile →
Citations per field
00.5×1.5×2.1×
Franz Kohlhuber · 1×
Citations per year

Countries citing papers authored by Julie A. Losman

Since Specialization
Citations

This map shows the geographic impact of Julie A. Losman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Losman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Losman more than expected).

Fields of papers citing papers by Julie A. Losman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Losman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Losman. The network helps show where Julie A. Losman may publish in the future.

Co-authorship network of co-authors of Julie A. Losman

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Losman. A scholar is included among the top collaborators of Julie A. Losman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Losman. Julie A. Losman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activationbreakdown →
566
2 44
3 55
4 167
5 101
6 127
7 18
8 157
9 58
10 33
11 30

About Julie A. Losman

Julie A. Losman is a scholar working on Pharmacology, Oncology and Hematology, having authored 11 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (7 papers), Pharmacological Effects of Natural Compounds (3 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Cancer Research (451 citations), Genetics (232 citations) and Immunology (441 citations). Julie A. Losman has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Paul B. Rothman, Douglas J. Hilton, Ulrich Bergmann, Roel G.W. Verhaak, Hai Yan, William G. Kaelin, Jeremy Travins, Peppi Koivunen, Stefan Größ and Ryan Looper. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026